Federated Hermes’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Federated Hermes’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,756	Closed	-$1.61M	–	2248
2023 Q2	$1.61M	Sell	15,756 -941	-6%	-$89K	﹤0.01%	1027
2023 Q1	$1.52M	Buy	+16,697	New	+$980K	﹤0.01%	1048
2020 Q2	–	Sell	-3,023	Closed	-$436K	–	2408
2020 Q1	$436K	Sell	3,023 -48,588	-94%	-$9.38M	﹤0.01%	1418
2019 Q4	$10.6M	Buy	51,611 +8,576	+20%	+$1.56M	0.02%	586
2019 Q3	$3.46M	Sell	43,035 -4,419	-9%	-$375K	0.01%	864
2019 Q2	$4.48M	Sell	47,454 -55,362	-54%	-$4.78M	0.01%	817
2019 Q1	$8.79M	Buy	+102,816	New	+$8.54M	0.02%	615
2018 Q4	–	Sell	-59,501	Closed	-$4.87M	–	2342
2018 Q3	$4.87M	Buy	+59,501	New	+$4.19M	0.01%	815

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Federated Hermes's RETA Position: Q3 2023 in Review

Federated Hermes sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 15,756 shares — an estimated $1.61M sold.

Federated Hermes first reported a position in RETA in Q3 2018 and held it in 8 quarters. The position peaked at $10.6M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Federated Hermes reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 15,756 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.61M.
Federated Hermes first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and held it in 8 quarters.
Federated Hermes's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $10.6M in Q4 2019.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.